New
Why participate?
Present the characteristics of tumor cells and the causes of therapeutic failure. Offer solutions through innovative therapies
Training context
Cancer accounts for a significant share of global mortality, with multiple and complex causes that traditional therapeutic approaches alone cannot fully address. It is essential to understand the reasons behind these failures in order to envision tomorrow’s innovative therapies.
Welcome and participant introductions
Introduction
Cancer in key figures
Cancer: definitions
Classification of cancers
Main risk factors
Properties of tumor cells
Key characteristics of a tumor cell
Fundamental aspects of cancer development
Main treatments for tumors
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Recurring issues in therapeutic failures
Recurrence due to incomplete elimination
Pharmacokinetic problems
Tumor mass heterogeneity
Advanced Therapy Medicinal Products (ATMPs)
CAR-T cells and gene therapy
Vaccines
Oncolytic viruses
Main models for preclinical proof of concept
In vitro models
In vivo models
General discussion, conclusion, and evaluation
Interactive Teaching, Case Studies, Experience Sharing
Researchers, technicians involved in tumor research and antitumor therapy programs
Basic knowledge of cell biology. Familiarity with preclinical drug development and/or pharmacology
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
